剖宫产感染预防中头孢菌素联合阿奇霉素的成本效果分析
研究构建成本效果模型,比较剖宫产预防性使用阿奇霉素联合头孢菌素与单用头孢菌素在70万例理论队列中的母婴结局。结果显示联合方案减少子宫内膜炎、脓毒症、静脉血栓栓塞和孕产妇死亡,并降低后续妊娠子宫破裂和剖宫产子宫切除,总体成本更低且质量调整生命年更高。只要阿奇霉素成本低于930美元即具成本效果。
要点
- 联合阿奇霉素较单用头孢菌素减少子宫内膜炎16,100例、脓毒症17例、静脉血栓栓塞8例、孕产妇死亡1例。
- 联合方案还预防后续妊娠子宫破裂36例和剖宫产子宫切除4例。
- 阿奇霉素成本低于930美元(基线成本27美元)时联合方案具成本效果。
核心结论
- 对于临产或胎膜破裂后行剖宫产的女性,与单用头孢菌素相比,加用阿奇霉素成本更低,并改善本次分娩及后续分娩的母体结局。
- 这些发现支持在剖宫产时预防性使用阿奇霉素。
研究设计与样本
- 使用TreeAge构建成本效果模型,在700,000名女性的理论队列中比较阿奇霉素联合头孢菌素与单用头孢菌素的结局。
- 该队列数量约为美国每年在产程中或胎膜破裂后进行的非择期剖宫产数量。
- 概率、效用值和成本来自文献,成本效果阈值设为每质量调整生命年100,000美元,并进行敏感性分析。
主要发现
- 与单用头孢菌素相比,联合阿奇霉素减少子宫内膜炎16,100例、脓毒症17例、静脉血栓栓塞8例、孕产妇死亡1例。
- 联合方案在后续妊娠中预防子宫破裂36例和剖宫产子宫切除4例。
- 总体而言,与标准头孢菌素预防相比,加用阿奇霉素成本更低且质量调整生命年更高。
- 敏感性分析显示,只要阿奇霉素成本低于930美元(基线成本27美元),该方案即具成本效果。
关键数值与推荐
- 成本效果阈值为每质量调整生命年100,000美元。
- 阿奇霉素成本低于930美元(基线成本27美元)时联合方案具成本效果。
临床怎么用
- 对于临产或胎膜破裂后行剖宫产的女性,作者认为这些发现支持在剖宫产时预防性使用阿奇霉素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the cost-effectiveness of adding azithromycin to standard cephalosporin regimens of cesarean delivery prophylaxis by considering the maternal outcomes in the current and potential subsequent pregnancies. METHODS: A cost-effectiveness model was created using TreeAge to compare the outcomes of using azithromycin-cephalosporin with cephalosporin alone in a theoretical cohort of 700,000 women, the approximate number of nonelective cesarean deliveries annually in the United States that occur during labor or after membrane rupture. Outcomes examined included endometritis, wound infection, sepsis, venous thromboembolism, and maternal death in the current pregnancy and uterine rupture, cesarean hysterectomy, and maternal death in subsequent pregnancies, including cost and quality-adjusted life-years for both pregnancies. Probabilities, utilities, and costs were derived from the literature, and a cost-effectiveness threshold was set at $100,000 per quality-adjusted life-year. Sensitivity analyses were used to determine the robustness of our results. RESULTS: Compared with cephalosporin alone for prophylaxis, our model showed 16,100 fewer cases of endometritis, 17 fewer cases of sepsis, eight fewer cases of venous thromboembolism, and one fewer maternal death with azithromycin-cephalosporin. Additionally, this strategy prevented 36 uterine ruptures and four cesarean hysterectomies in the subsequent pregnancy. Overall, the addition of azithromycin led to both lower costs and higher quality-adjusted life-years when compared with standard cephalosporin prophylaxis. In sensitivity analysis, we found that as long as the cost of azithromycin remained below $930 (baseline cost $27), it was cost-effective. CONCLUSION: For women who undergo cesarean delivery in labor or after membrane rupture, compared with cephalosporin alone, the addition of azithromycin to cesarean delivery infection prophylaxis is less costly and leads to better maternal outcomes in the index delivery and subsequent deliveries. These findings support the use of prophylactic azithromycin at the time of cesarean delivery.
引用
- Skeith AE, Niu B, Valent AM, et al. Adding Azithromycin to Cephalosporin for Cesarean Delivery Infection Prophylaxis: A Cost-Effectiveness Analysis. Obstet Gynecol. 2017. PMID: 29112658. doi:10.1097/AOG.0000000000002333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。